Evidence map›Paper›PMID 29654346›Full record

ReviewPsychopharmacology2018

Targeting the intracellular signaling "STOP" and "GO" pathways for the treatment of alcohol use disorders.

Dorit Ron, Anthony Berger

Open access · hybridAbstract readReview
In one paragraph

Review in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. BDNF in ventrolateral orbitofrontal cortex to dorsolateral striatum circuit moderates alcohol consumption, seeking and relapse.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Alcohol and the brain: from genes to circuits.Trends in neurosciences · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Growth Factors and Alcohol Use Disorder.Cold Spring Harbor perspectives in medicine · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dorit RonDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA. Dorit.Ron@ucsf.edu.
Anthony BergerDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
University of California, San Francisco · US

Funding

Vector, Transgenic, and Imaging CoreP50AA017072 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOPF, FREDERIC WOODWARD · 2008 to 2017
$13.9M
BDNF and Alcohol AddictionR37AA016848 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RON, DORIT · 2013 to 2022
$3.7M
Pathway-specific Fyn signaling in the striatum and ethanol drinkingU01AA023489 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RON, DORIT · 2014 to 2018
$1.8M
NIAAA NIH HHS P50 AA017072NIAAA NIH HHS R37 AA016848NIAAA NIH HHS U01 AA023489
6 · The paper itself

Abstract

In recent years, research has identified the molecular and neural substrates underlying the transition of moderate "social" consumption of alcohol to the characteristic alcohol use disorder (AUD) phenotypes including excessive and compulsive alcohol use which we define in the review as the GO signaling pathways. In addition, growing evidence points to the existence of molecular mechanisms that keep alcohol consumption in check and that confer resilience for the development of AUD which we define herein as the STOP signaling pathways. In this review, we focus on examples of the GO and the STOP intracellular signaling pathways and discuss our current knowledge of how manipulations of these pathways may be used for the treatment of AUD.

Indexed as

Alcohol DrinkingAlcoholismAnimalsBenzodioxolesBrain-Derived Neurotrophic FactorDrug Delivery SystemsEthanolHumansIntracellular FluidQuinazolinesSignal TransductionSirolimusTreatment OutcomeBenzodioxolesBrain-Derived Neurotrophic FactorEthanolQuinazolinessaracatinibSirolimusAddictionAlcoholBDNFFynGDNFMedication DevelopmentmTORSignalingTranslation

Identifiers

PMID29654346
PMCPMC5949137
OpenAlexW2796923285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.